enlivex.com (ENLV) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Enlivex Therapeutics (ENLV) butun dunyodagi intensiv terapiya bo'limlari uchun sepsisga qarshi hujayraviy terapiyalarni ishlab chiqadi. Qattiq o'smalar uchun terapiyalarning ishlab chiqilishi loyihalar portfelini kengaytirib, sinovlar muvaffaqiyatsiz tugash ehtimolini minimallashtiradi. Biroq, tadqiqot va ishlanmalar (R&D) xarajatlari hamda nojo'ya ta'sirlar xavfi moliyaviy beqarorlikni yuzaga keltirmoqda. Uzoq muddatli qarzlarning kapitalga nisbati to'lov qobiliyatini aniq namoyish etadi, bunda 0.00 ko'rsatkichi leveraj metrikasining holatini ifodalaydi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ENLV_-_Enlivex-Therapeutics_-_Long-Term-Debt-to-Capital "ENLV: Enlivex Therapeutics, Ltd. Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 | 👁️GURU.Markets👁️")
Enlivex Therapeutics Ltd (ENLV) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Enlivex Therapeutics|ENLV - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Enlivex Therapeutics, Ltd.|ENLV - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Enlivex Therapeutics Ltd.|ENLV - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Enlivex Therapeutics|Tezkor likvidlik ko‘rsatkichi enlivex.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:enlivex.com - ENLV
Investorlar risklarni minimallashtirish uchun Enlivex Therapeutics (ENLV) majburiyatlar tuzilmasining barqarorligini baholashlari kerak. Ushbu metrika uzoq muddatli qarzlarining kapitalga nisbatan ulushini o'lchab, kompaniyaning moliyaviy qaramlik darajasini aniqlaydi. Uzoq muddatli qarzning kapitalga nisbati tahlili orqali yashirin qarz yuklarini aniqlash mumkin. Bu ko'p yillik FDA nazorati davrida juda muhimdir. IT platformasining patent himoyasi kredit risklarini minimallashtirgan holda kapitalni jalb qilish imkonini beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|Septerna Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pieris Corp|Savara Inc. (SVRA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi RIGL|Uzoq muddatli qarzning o'z kapitaliga nisbati AnaptysBio|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning kapitalga nisbati ENGN|Uzoq muddatli qarzdorlikning kapitalga nisbati rapt.com|Aerovate Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|aclaristx.com - Uzoq muddatli qarzning o'z kapitaliga nisbati|Kyverna Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Tiziana Life Sciences Ltd.|CABA (Cabaletta Bio, Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi VTYX|Uzoq muddatli qarzning o'z kapitaliga nisbati THTX|AVTX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ELDN (Eledon Pharmaceuticals, Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati AGEN|Uzoq muddatli qarzning kapitalga nisbati CLYM (Climb Bio, Inc.)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ZURA|aTyr Pharma, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Adagene|ikenaoncology.com (IMA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Shattuck Labs - Uzoq muddatli qarzning kapitalga koeffitsiyenti|EQ (Equillium Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Connect Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunic, Inc. (IMUX)|ATRA: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati IFRX (InflaRx)|X4 Pharmaceuticals Inc. (XFOR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|ACET: Uzoq muddatli qarzning o'z kapitaliga nisbati|CELU - Uzoq muddatli qarzning kapitalga nisbati|INMB (INmune Bio, Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|BRNS: Uzoq muddatli kreditlarning kapitalga nisbati|KZR (Kezar Life Sciences, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|SAB Biotherapeutics Inc. (SABS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati AKTX|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzdorlikning kapitalga nisbati edesabiotech.com (EDSA)|iBio - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Carisma Therapeutics|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BOLT|Uzoq muddatli qarzning o'z kapitaliga nisbati HCW Biologics, Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati APVO|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|Uzoq muddatli qarzning o'z kapitaliga nisbati ADTX (aditxt.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati